Thu, Feb 1, 2024 2:56 PM
Dr Lal PathLabs net profit zooms 54% to Rs 81.3 crore in Q3
A Flip by Avya Verma
Niva Bupa Health Insurance Company could not enthuse investors on its debut day as shares closed flat, following weak conditions in the equity markets on November 14. The Nifty 50 has shed 10.4 percent from its record high of September 27. The stock opened higher at Rs 78.14 on the NSE, up 5.6 percent over the issue price and hit an intraday high of Rs 81 in early trade.
Open Flip
Motilal Oswal's research report on Bosch: Bosch's 2QFY25 results beat estimates due to lower raw material costs, driven by localization efforts. However, auto demand remains weak, and margin pressure persists with no near-term improvement visibility. The stock is fairly valued at ~45x FY25E/38x FY26E EPS, with a Neutral stance and TP of INR34,280.
Open Flip
BSE reported strong 2QFY25 results, with 192% YoY and 31% QoQ PAT growth to INR3.46b, driven by revenue growth and operational efficiency. Operating revenue grew 137% YoY to INR7.5b, with a 100% YoY jump in Star MF revenue. EBITDA margins expanded to 52.1%. BSE reported strong 2QFY25 results, with 192% YoY and 31% QoQ PAT growth to INR3.46b, driven by revenue growth and operational efficiency.
Open Flip
